Richmond Journal of Law and Technology
Volume 10 | Issue 2

Article 10

2003

Panel Remarks on Regulating Genetically Modified
Foods: Is Mandatory Labeling the Right Answer?
Michael Rodemeyer
Jonathan Adler
Greg Conko
Jean Halloran

Follow this and additional works at: http://scholarship.richmond.edu/jolt
Part of the Administrative Law Commons, and the Agriculture Law Commons
Recommended Citation
Michael Rodemeyer, Jonathan Adler, Greg Conko & Jean Halloran, Panel Remarks on Regulating Genetically Modified Foods: Is
Mandatory Labeling the Right Answer?, 10 Rich. J.L. & Tech 15 (2003).
Available at: http://scholarship.richmond.edu/jolt/vol10/iss2/10

This Article is brought to you for free and open access by UR Scholarship Repository. It has been accepted for inclusion in Richmond Journal of Law
and Technology by an authorized administrator of UR Scholarship Repository. For more information, please contact
scholarshiprepository@richmond.edu.

Food Biotechnology: A Legal Perspective- Mandatory Labeling Panel

PANEL REMARKS ON REGULATING GENETICALLY MODIFIED FOODS:
IS MANDATORY LABELING THE RIGHT ANSWER?
Moderated by: Michael Rodemeyer*
Participants: Jonathan Adler, Greg Conko, Jean Halloran
Cite As: Michael Rodemeyer et al., Symposium: Panel Remarks on Regulating Genetically
Modiﬁed Foods: Is Mandatory Labeling the Right Answer?, 10 RICH. J.L. & TECH. 15 (2003),
at http://law.richmond.edu/jolt/v10i2/article15.pdf.

Mr. Michael Rodemeyer:

{1} Thank you to all of our speakers. I can assure everybody in the
audience that you will not be specialists on this topic after today, since
we can easily spend a whole afternoon on this topic. Let me ask Jean
ﬁrst of all, do you want to respond to anything you’ve heard from the
speakers after you?

Ms. Jean Halloran:

{2} Yes. In particular, in terms of Mr. Conko’s remarks on why should
we label genetically engineered foods and that isn’t it just enough to
have organic choices or non-engineered, I say that consumers didn’t ask
for genetic engineering of foods.
{3} The question arises as to where the burden of labeling should fall.
Should it fall on the entity that introduces the technology? Should they
be able to just go ahead and then pass the burden of labeling, or the cost
of labeling, on all the people who are producing foods in the same ways
that they have for decades or hundreds of years? We think the burden
should fall on those that are introducing the new technology that
consumers have the right to know about.
{4} In terms of constitutional issues raised, those are interesting issues,
and my organization has a lot of doubts as to whether corporations
should have the same free speech rights, political free speech right
and commercial free speech rights, but in terms of the Vermont case that
you were mentioning, that was a decision of a three-judge panel where
there was one dissenting judge and two in favor of the ruling, so
that wasn’t exactly a slam dunk legal decision. It seems as though the
argument could be equally applied to Country of Origin labeling. This
is not a health related issue; I’d be interested to hear any comments on
that.
{5} Finally, you know, isn’t this like crosses? It’s a matter of opinion,
but in our view, moving bacterial genes and viral genes from whole
different families is not the same as a wide cross between two members
of a related family, and surely ﬁsh genes into strawberries is something
quite different.
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Mr. Michael Rodemeyer:

{6} Mr. Conko, we’ll move to you. Would you like to respond to Ms.
Halloran, or are there any remarks that you would like to discuss to at
this point?

Mr. Gregory Conko:

{7} I think I’ll just restrict my comments to what Jean just said.
Consumers didn’t ask for genetically engineered foods. Fair enough.
What food breeding technique in the last hundred years did they ask
for? And why is Consumers Union not opposed to mutation breeding,
wide crosses, embryo rescue, chromosome doubling –

Ms. Jean Halloran:

{8} We’re not opposed to genetic engineering – we just want to label it.

Mr. Gregory Conko:

{9} Okay, so why not label every one of these?

Ms. Jean Halloran:

{10} We don’t think there’s a signiﬁcant difference.

Mr. Gregory Conko:

{11} I see. And why A crosses between, say, a toxic tomato and food
grade tomato is unimportant and doesn’t need to be labeled, whereas
transferring a single non-toxic gene from say an animal or a ﬁsh into a
strawberry would be, I don’t understand. Genes are genes, and they create
proteins, or they create other gene products, which individually can be
tested for safety, and which apart from their host organism and apart for
their parent organism have no identity.
{12} Genetically, human beings are ninety-eight and one-half percent
(98.5%) chimpanzees. So, would the addition of a single chimp gene into
my body make me a chimpanzee? We share at least forty percent (40%)
of our genes with a plant called Arabidopsis thaliana. If I have one
Arabidopsis thaliana gene put into my body, does that make me a wild
mustard plant? The question is not what is the source of the gene, the
question is what does a gene do and are the gene and the gene product
safe?

Ms. Jean Halloran:

{13} There are two profoundly different ways of looking at this. One
is to just say, “We’re all just made of genes and there’s one giant gene
pool and it doesn’t matter if we differentiate.” The other one is to say,
“There are differences between a chimpanzee and a human, and it does
matter if you’re moving from one to the other.” I think this is ultimately a
value decision and one where democracy ought to have a chance to
prevail in terms of what most people think.

Mr. Michael Rodemeyer:

{14} Let me ask one question and then let’s take one question from
the audience. Greg, you mentioned the issue about information in a
voluntary labeling scheme, that if people truly want this product, then
people would be able to label and to respond to labeling on GM foods. I
wondered if you would comment on the issue that the FDA right now is
actually very restrictive on the ability of companies to say that their
products do not contain genetically modiﬁed organisms.
{15} The reason for the restrictive policy is that there is a question about
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whether or not that label would be misleading in part because of the
problem that I think David Hoover mentioned earlier, which is that there’s
a very low level of genetically modiﬁed foods throughout the
conventional food supply, and even organic producers now ﬁnd it
difﬁcult to avoid having some level of genetically modiﬁed ingredients
in their products. So if you claim that it is free of those GM substances,
in fact in most cases it isn’t, so FDA’s been tough on that. Also we
should address the issue about FDA wanting to require an additional
disclosure, as they did with the recombinant DNA growth hormone, that
says that there’s no difference between GM and non-GM products. So it
makes it difﬁcult for people to voluntarily label non-GMO’s.
Mr. Gregory Conko:

{16} I think generally the approach and the concern the FDA has laid
out with a generic non-genetically modiﬁed label, or “No GMO’s” is a
valid one, in that genetic modiﬁcation is a term that for most of the
twentieth century meant to scientists something very different than
what it means today. So it’s a term that means one thing to one group of
people and means an entirely different thing to another group of people.
To the extent that a food producer would like to be speciﬁc,
bioengineering is a term that was invented speciﬁcally for the purpose of
talking about the techniques of recombinant DNA engineering.
{17} I think if a food producer was to label this product nonbioengineered or from ingredients that are non-bioengineered, I think that
would clear that misconception.
{18} Now as for the residual trace amounts, that raises another issue. I
think that could be taken care of with a tolerance level, as we have for
things like hair and rat feces in soybeans and corn and other things now
companies aren’t necessarily labeling on their products. Well, this is corn
but it has soybeans in it, which may be factually incorrect if there does
happen to be a soybean. I think it’s a question that we can work through,
and I think that a reasonable policy would be allowed to set tolerances at
another level.
{19} As for the disclaimer, the last issue, regarding Ben & Jerry’s, I
think FDA reached the wrong conclusion in that regard. It was one thing
for the FDA to require Ben & Jerry’s not simply to say that there’s no
RBST in it’s dairy products, but to be speciﬁc and say, it’s from the dairy
products are from cows that haven’t been treated with RBST and to also
make an explicit disclaimer by saying that the FDA has found no
difference between RBST treated cows and non-RBST treated cows, I
think was a step over the line in FDA’s part.
{20} I think producers have every right to label accurately and in that
regard I don’t believe that it would have presented a serious
misrepresentation to consumers. Just to make the particularly especially
valid claim that dairy products come from cows that have been treated
with RBST.
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Mr. Michael Rodemeyer:

{21} Let me take one question from the audience. Yes sir.

Audience:

{22} When I look at all the various lists associated with various
agricultural processes and technologies, part of me wonders why so many
people are concerned about the labeling of genetic engineering. It doesn’t
say anything about requiring labeling of foods that have been treated
with conventional pesticides, I don’t see in the produce section when
foods are treated with organic phosphates or antibiotics. The residues are
in our food. I mean that’s seems to be a risk that’s probably more so than
to genetically modiﬁed foods so far.

Mr. Michael Rodemeyer:

{23} Jean.

Ms. Jean Halloran:

{24} Personally speaking, I would also like to see mandatory labeling
of pesticides treated and antibiotics used in feed of animals, and I think
maybe my organization would, too. It hasn’t arisen as a political issue
because it’s been with us for a long time. The rareness and the problems
with these substances has kind of gradually come upon us, whereas
genetic engineering has suddenly appeared on the scene. I think a lot of
people who are activists feel as though with this technology we have
a chance to do what we should have done and failed to do and realized
what the problems were with pesticides. Had we known the problems
with pesticides, a lot of folks might have objected to them and might have
had controls over them a lot earlier on.

Mr. Gregory Conko:

{25} I think you’re misreading the history a little bit Jean. In fact,
there were attempts in the late 1950’s and through the early 1960’s to
mandate pesticide application information, and require labeling on food
products. With that, there was another case in which a labeling law was
struck down by courts as being unconstitutional -- although I’ll
acknowledge that I don’t believe that case made it to the level of the
Supreme Court either. So, this isn’t an entirely new thing here either.
{26} A lot of these questions and concerns go back even before Rachel
Carson. The Delaney Clause in the Food, Drug, and Cosmetic Act, which
was in 1956 or 1958, marked probably the high water mark of America’s
ﬁrst chemical scare, and there’s nothing new under the sun so to speak.
These are all issues that, I think, conceptually deal with different but
similar technologies.

Prof. Jonathan Adler:

{27} Responding to Jean’s earlier remarks, ﬁrst on the issue of
commercial speech, it does not have the same level of protection as
political speech, and that is a distinction that most of the Justices in the
court hold to, but there are some that think the distinction is invalid.
More importantly, commercial speech, while it does not get the full level
of protection as political speech, still does get signiﬁcant protection.
{28} With regard to labels, what’s interesting here (and for those of
you in agricultural law), we see this distinction made in the various
marketing order cases. There’s a difference between an isolated label
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requirement, as would be mandated for GMOs, and a disclosure
requirement that is part of a larger regulatory apparatus that needs that
information disclosure for the apparatus to work. This distinction is
illustrated by the cases involving marketing orders for various types of
produce. The Supreme Court held that when that compelled commercial
speech is part of the broader regulatory scheme, then it might be okay,
because the regulatory scheme may be okay. When the disclosure
requirement is by itself, on the other hand -- which occurred in a recent
case, United States v. United Foods, just two years ago, the court said
you cannot compel. It is hard to see how a GMO label would be an
integral part of a broader regulatory scheme. In the case of Country of
Origin labels, however, there are regulations concerning safety standards,
tariffs, and the like, which may require information about where things
came from.
Mr. Michael Rodemeyer:

{29} Thank you all for your participation today.
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